Results 161 to 170 of about 11,721 (222)

[Bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia].

open access: yesAnales de medicina interna (Madrid, Spain : 1984), 1998
J L, Alvarez-Sala   +3 more
openaire   +1 more source

Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome. [PDF]

open access: yesTranspl Int
Matsudo K   +10 more
europepmc   +1 more source

Bronchiolitis Obliterans

Clinical Pediatrics, 1975
A case of severe, probably viral pneumonitis in a three-year-old child is presented, which resulted in complete atelectasis of the left lung, and in diffuse changes of bronchiolitis and bronchitis obliterans. The case represents a variant of bronchiolitis obliterans.
H, Azizirad   +3 more
openaire   +2 more sources

Bronchiolitis Obliterans

Seminars in Respiratory and Critical Care Medicine, 2000
Bronchiolitis obliterans (BO) is a fibrotic lung disease involving the small conducting airways. BO may be classified by etiology and underlying disease or, more commonly, by histopathological pattern. The two major histopathological categories are (1) BO organizing pneumonia (BOOP) and proliferative bronchiolitis and (2) constrictive bronchiolitis ...
L, Angel, A, Homma, S M, Levine
openaire   +2 more sources

Bronchiolitis Obliterans

Clinical Reviews in Allergy & Immunology, 2003
Bronchiolitis obliterans (BO) is a disease of small airways that results in progressive dyspnea and airflow limitation. It is a common sequela of bone marrow, lung, and heart-lung transplantation, but can also occur as a complication of certain pulmonary infections, adverse drug reaction, toxic inhalation, and autoimmune disorders.
Petey, Laohaburanakit   +2 more
openaire   +2 more sources

Bronchiolitis Obliterans Syndrome

2023
Bronchiolitis obliterans (BO) is the only late-onset pulmonary complication after allogeneic hematopoietic stem cell transplantation (HSCT) to be recognized as a pulmonary graft-versus-host disease, affecting approximately 10% of HSCT recipients. Although the diagnosis of BO used to require a lung biopsy, it is now based primarily on pulmonary function
Louise Bondeelle, Anne Bergeron
openaire   +2 more sources

Home - About - Disclaimer - Privacy